Battelle Team Wins DARPA Contract to Build Medical Device to Treat Sepsis
Up to $22.83M in funds to be allocated for the Battelle, NxStage and Aethlon collaboration to develop an advanced portable medical device for DARPA-and ultimately civilian-use.
COLUMBUS, Ohio- At Battelle, supporting America's military personnel is woven into the fabric of its business. In that pursuit, a team consisting of Battelle, NxStage Medical (NXTM), Inc. and Aethlon Medical (AEMD) has won a contract from the Defense Advanced Research Projects Agency, or DARPA, to develop an innovative, new medical device that may save the lives of soldiers-and civilians as well-by treating sepsis.